Evidence map›Paper›PMID 33827915›Full record

Trial reportStroke and vascular neurology2021

Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well: results from the MR CLEAN Registry.

Luuk Dekker, Esmee Venema, F Anne V Pirson, Charles B L M Majoie, Bart J Emmer, Ivo G H Jansen, Maxim J H L Mulder, Robin Lemmens, Robert-Jan B Goldhoorn, Marieke J H Wermer and 10 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Stroke and vascular neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Safety and efficacy of endovascular treatment for acute ischemic stroke of large-vessel occlusion beyond the time window based on imaging evaluation.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Article
  8. Review
  9. In search of real-world cerebroprotection: An institutional perspective and review of the literature.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Luuk DekkerNeurology, Leiden University Medical Centre, Leiden, The Netherlands.ORCID 0000-0002-0958-2081
Esmee VenemaNeurology, Erasmus MC, Rotterdam, The Netherlands e.venema@erasmusmc.nl.ORCID 0000-0003-1631-6635
F Anne V PirsonNeurology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Charles B L M MajoieRadiology and Nuclear Medicine, Amsterdam University Medical Centre, Location AMC, Amsterdam, The Netherlands.
Bart J EmmerRadiology and Nuclear Medicine, Amsterdam University Medical Centre, Location AMC, Amsterdam, The Netherlands.
Ivo G H JansenRadiology and Nuclear Medicine, Amsterdam University Medical Centre, Location AMC, Amsterdam, The Netherlands.
Maxim J H L MulderNeurology, Erasmus MC, Rotterdam, The Netherlands.
Robin LemmensNeurology, University Hospitals Leuven, Leuven, Belgium.
Robert-Jan B GoldhoornNeurology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Marieke J H WermerNeurology, Leiden University Medical Centre, Leiden, The Netherlands.
Jelis BoitenNeurology, Haaglanden Medical Centre, Den Haag, The Netherlands.
Geert J Lycklama À NijeholtRadiology, Haaglanden Medical Centre, Den Haag, The Netherlands.
Yvo B W E M RoosNeurology, Amsterdam University Medical Centre, Location AMC, Amsterdam, The Netherlands.
Adriaan C G M van EsRadiology, Haaglanden Medical Centre, Den Haag, The Netherlands.
Hester F LingsmaPublic Health, Erasmus MC, Rotterdam, The Netherlands.
Diederik W J DippelNeurology, Erasmus MC, Rotterdam, The Netherlands.
Wim H van ZwamRadiology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Robert J van OostenbruggeNeurology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Ido R van den WijngaardNeurology, Leiden University Medical Centre, Leiden, The Netherlands.
MR CLEAN Registry investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRandomised controlled trials with perfusion selection have shown benefit of endovascular treatment (EVT) for ischaemic stroke between 6 and 24 hours after symptom onset or time last seen well. However, outcomes after EVT in these late window patients without perfusion imaging are largely unknown. We assessed their characteristics and outcomes in routine clinical practice.

methodsThe Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands Registry, a prospective, multicentre study in the Netherlands, included patients with an anterior circulation occlusion who underwent EVT between 2014 and 2017. CT perfusion was no standard imaging modality. We used adjusted ordinal logistic regression analysis to compare patients treated within versus beyond 6.5 hours after propensity score matching on age, prestroke modified Rankin Scale (mRS), National Institutes of Health Stroke Scale, Alberta Stroke Programme Early CT Score (ASPECTS), collateral status, location of occlusion and treatment with intravenous thrombolysis. Outcomes included 3-month mRS score, functional independence (defined as mRS 0-2), and death.

resultsOf 3264 patients who underwent EVT, 106 (3.2%) were treated beyond 6.5 hours (median 8.5, IQR 6.9-10.6), of whom 93 (87.7%) had unknown time of stroke onset. CT perfusion was not performed in 87/106 (80.2%) late window patients. Late window patients were younger (mean 67 vs 70 years, p<0.04) and had slightly lower ASPECTS (median 8 vs 9, p<0.01), but better collateral status (collateral score 2-3: 68.3% vs 57.7%, p=0.03). No differences were observed in proportions of functional independence (43.3% vs 40.5%, p=0.57) or death (24.0% vs 28.9%, p=0.28). After matching, outcomes remained similar (adjusted common OR for 1 point improvement in mRS 1.04, 95% CI 0.56 to 1.93).

conclusionsWithout the use of CT perfusion selection criteria, EVT in the 6.5-24-hour time window was not associated with poorer outcome in selected patients with favourable clinical and CT/CT angiography characteristics. randomised controlled trials with lenient inclusion criteria are needed to identify more patients who can benefit from EVT in the late window.

Indexed as

Brain IschemiaEndovascular ProceduresIschemic StrokeStrokeHumansProspective StudiesRegistriesThrombectomyUnited StatesStrokeThrombectomy

Identifiers

PMID33827915
PMCPMC8717786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.